Alnylam Pharmaceuticals, Inc. (ALNY)
BMV
Closed
Oct 6, 2026
Day's Range
5,549.0052 wk Range
5,150.16Overview - ALNY - Alnylam Pharmaceuticals, Inc.
Key Statistics
Valuation
Enterprise Value
13.58T
P/E (Trailing)
‪53.47‬
PEG Ratio
‪-0.15‬
Price / Sales (TTM)
‪154.55‬
Price / Book
‪30.30‬
EV / EBITDA
‪703.80‬
Profitability
Gross Margin
‪76.88%‬
Profit Margin
‪16.12%‬
Operating Margin
‪17.92%‬
Return on Assets
‪12.34%‬
Return on Equity
‪96.55%‬
Ownership
Shares Outstanding
133.73M
Float
133.23M
Held by Insiders
‪0.18%‬
Held by Institutions
‪101.79%‬
Price stats
Beta
‪0.30‬
50-Day Avg
‪5,549.00‬
200-Day Avg
‪6,781.80‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Annual
Market Cap - ALNY - Alnylam Pharmaceuticals, Inc.
Peers - ALNY - Alnylam Pharmaceuticals, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on BMV.
- ALNYBMVAlnylam Pharmaceuticals, Inc.742.50BMarket Cap-51.02%52-week change53.47P/E (Trailing)‪16.12%‬Profit Margin
- ARGXNBMVargenx SE American Depositary Receipt1.05TMarket Cap+10.77%52-week change36.36P/E (Trailing)‪32.26%‬Profit Margin
- BNTXNBMVBioNTech SE American Depositary Share413.38BMarket Cap-18.50%52-week change1.65P/E (Trailing)‪-63.63%‬Profit Margin
- ASND1NBMVAscendis Pharma A/S291.08BMarket Cap+3.50%52-week change19.80P/E (Trailing)‪70.84%‬Profit Margin
- BMRNBMVBioMarin Pharmaceutical Inc.213.89BMarket Cap+10.22%52-week change172.39P/E (Trailing)‪2.14%‬Profit Margin
- AGIOBMVAgios Pharmaceuticals, Inc.72.95BMarket Cap+0.00%52-week change5.17P/E (Trailing)‪88.25%‬Profit Margin
- ARWRBMVArrowhead Pharmaceuticals, Inc.64.02BMarket Cap+0.00%52-week change-45455.00P/E (Trailing)‪-47.79%‬Profit Margin
Profile Summary - ALNY - Alnylam Pharmaceuticals, Inc.
About
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company focused on RNA interference therapeutics. Alnylam Pharmaceuticals develops, manufactures, and commercializes medicines designed to silence disease-causing genes, with a primary emphasis on rare genetic and cardiometabolic conditions. Its current portfolio…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
